HEADER SIGNALING PROTEIN 05-DEC-16 5WS3 TITLE CRYSTAL STRUCTURES OF HUMAN OREXIN 2 RECEPTOR BOUND TO THE SELECTIVE TITLE 2 ANTAGONIST EMPA DETERMINED BY SERIAL FEMTOSECOND CRYSTALLOGRAPHY AT TITLE 3 SACLA COMPND MOL_ID: 1; COMPND 2 MOLECULE: OREXIN RECEPTOR TYPE 2,GLGA GLYCOGEN SYNTHASE,OREXIN COMPND 3 RECEPTOR TYPE 2; COMPND 4 CHAIN: A; COMPND 5 FRAGMENT: UNP RESIDUES 3-254,UNP RESIDUES 218-413,UNP RESIDUES 294- COMPND 6 388; COMPND 7 SYNONYM: OX2R,HYPOCRETIN RECEPTOR TYPE 2,GLYCOGEN SYNTHASE; COMPND 8 ENGINEERED: YES; COMPND 9 OTHER_DETAILS: CHIMERA PROTEIN OF UNP RESIDUES 3-254 FROM OREXIN COMPND 10 RECEPTOR TYPE 2 (O43614), UNP RESIDUES 218-413 FROM GLGA GLYCOGEN COMPND 11 SYNTHASE (Q9V2J8), UNP RESIDUES 294-388 FROM OREXIN RECEPTOR TYPE 2 COMPND 12 (O43614) SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS, PYROCOCCUS ABYSSI (STRAIN GE5 / SOURCE 3 ORSAY); SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606, 272844; SOURCE 6 STRAIN: GE5 / ORSAY; SOURCE 7 GENE: HCRTR2, PAB2292; SOURCE 8 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS RECEPTOR, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR R.SUNO,K.KIMURA,T.NAKANE,K.YAMASHITA,J.WANG,T.FUJIWARA,Y.YAMANAKA, AUTHOR 2 D.IM,H.TSUJIMOTO,M.SASANUMA,S.HORITA,T.HIROKAWA,E.NANGO,K.TONO, AUTHOR 3 T.KAMESHIMA,T.HATSUI,Y.JOTI,M.YABASHI,K.SHIMAMOTO,M.YAMAMOTO, AUTHOR 4 D.M.ROSENBAUM,S.IWATA,T.SHIMAMURA,T.KOBAYASHI REVDAT 6 23-OCT-24 5WS3 1 REMARK REVDAT 5 08-NOV-23 5WS3 1 REMARK REVDAT 4 06-SEP-23 5WS3 1 REMARK REVDAT 3 20-JUN-18 5WS3 1 JRNL REVDAT 2 31-JAN-18 5WS3 1 REMARK REVDAT 1 13-DEC-17 5WS3 0 JRNL AUTH R.SUNO,K.T.KIMURA,T.NAKANE,K.YAMASHITA,J.WANG,T.FUJIWARA, JRNL AUTH 2 Y.YAMANAKA,D.IM,S.HORITA,H.TSUJIMOTO,M.S.TAWARAMOTO, JRNL AUTH 3 T.HIROKAWA,E.NANGO,K.TONO,T.KAMESHIMA,T.HATSUI,Y.JOTI, JRNL AUTH 4 M.YABASHI,K.SHIMAMOTO,M.YAMAMOTO,D.M.ROSENBAUM,S.IWATA, JRNL AUTH 5 T.SHIMAMURA,T.KOBAYASHI JRNL TITL CRYSTAL STRUCTURES OF HUMAN OREXIN 2 RECEPTOR BOUND TO THE JRNL TITL 2 SUBTYPE-SELECTIVE ANTAGONIST EMPA. JRNL REF STRUCTURE V. 26 7 2018 JRNL REFN ISSN 1878-4186 JRNL PMID 29225076 JRNL DOI 10.1016/J.STR.2017.11.005 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (DEV_2747: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 45.11 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 28958 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.219 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.970 REMARK 3 FREE R VALUE TEST SET COUNT : 1440 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 45.1173 - 4.9532 0.99 2804 162 0.1971 0.2028 REMARK 3 2 4.9532 - 3.9322 1.00 2768 145 0.1748 0.1930 REMARK 3 3 3.9322 - 3.4354 1.00 2752 131 0.1798 0.1930 REMARK 3 4 3.4354 - 3.1214 1.00 2763 159 0.1939 0.2386 REMARK 3 5 3.1214 - 2.8977 1.00 2748 151 0.1978 0.2323 REMARK 3 6 2.8977 - 2.7269 1.00 2734 139 0.2002 0.2264 REMARK 3 7 2.7269 - 2.5903 1.00 2748 144 0.2380 0.2970 REMARK 3 8 2.5903 - 2.4776 1.00 2719 145 0.2646 0.3122 REMARK 3 9 2.4776 - 2.3822 1.00 2740 130 0.3202 0.3679 REMARK 3 10 2.3822 - 2.3000 1.00 2742 134 0.3974 0.4361 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.370 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.500 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 4310 REMARK 3 ANGLE : 0.714 5814 REMARK 3 CHIRALITY : 0.047 651 REMARK 3 PLANARITY : 0.004 708 REMARK 3 DIHEDRAL : 11.864 2586 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 35 THROUGH 251 ) REMARK 3 ORIGIN FOR THE GROUP (A): 46.2769 40.0896 -46.8419 REMARK 3 T TENSOR REMARK 3 T11: 0.5561 T22: 0.4614 REMARK 3 T33: 0.5701 T12: 0.0067 REMARK 3 T13: 0.0971 T23: 0.0012 REMARK 3 L TENSOR REMARK 3 L11: 1.1586 L22: 2.4917 REMARK 3 L33: 3.0250 L12: 0.0548 REMARK 3 L13: -0.0566 L23: -0.1264 REMARK 3 S TENSOR REMARK 3 S11: -0.0879 S12: 0.1059 S13: -0.0111 REMARK 3 S21: -0.0685 S22: -0.0104 S23: -0.0417 REMARK 3 S31: -0.0711 S32: -0.0662 S33: 0.0888 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 252 THROUGH 383 ) REMARK 3 ORIGIN FOR THE GROUP (A): 39.600 47.049 -39.435 REMARK 3 T TENSOR REMARK 3 T11: 0.7632 T22: 0.5345 REMARK 3 T33: 0.5803 T12: 0.0068 REMARK 3 T13: 0.0661 T23: -0.0133 REMARK 3 L TENSOR REMARK 3 L11: 0.3297 L22: 0.0966 REMARK 3 L33: 3.6996 L12: 0.1314 REMARK 3 L13: -1.0812 L23: -0.5477 REMARK 3 S TENSOR REMARK 3 S11: 0.0115 S12: 0.0157 S13: -0.0280 REMARK 3 S21: -0.0572 S22: -0.0494 S23: -0.0457 REMARK 3 S31: -0.0962 S32: -0.0989 S33: 0.0482 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5WS3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 07-DEC-16. REMARK 100 THE DEPOSITION ID IS D_1300002299. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-APR-15 REMARK 200 TEMPERATURE (KELVIN) : 293 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : FREE ELECTRON LASER REMARK 200 BEAMLINE : BL3 REMARK 200 X-RAY GENERATOR MODEL : SACLA BEAMLINE BL3 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.77 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MPCCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28958 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 77.60 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 5.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.4 REMARK 200 DATA REDUNDANCY IN SHELL : 7.20 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 4S0V REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 51.42 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.53 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M MES, 0.1M SODIUM MALONATE, 27-30% REMARK 280 PEG 300, PH 6.0, LIPIDIC CUBIC PHASE, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 48.75500 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.99000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 48.75500 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 37.99000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 310 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25810 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A -6 REMARK 465 TYR A -5 REMARK 465 LYS A -4 REMARK 465 ASP A -3 REMARK 465 ASP A -2 REMARK 465 ASP A -1 REMARK 465 ASP A 0 REMARK 465 ALA A 1 REMARK 465 MET A 2 REMARK 465 GLY A 3 REMARK 465 THR A 4 REMARK 465 LYS A 5 REMARK 465 LEU A 6 REMARK 465 GLU A 7 REMARK 465 ASP A 8 REMARK 465 SER A 9 REMARK 465 PRO A 10 REMARK 465 PRO A 11 REMARK 465 CYS A 12 REMARK 465 ARG A 13 REMARK 465 ASN A 14 REMARK 465 TRP A 15 REMARK 465 SER A 16 REMARK 465 SER A 17 REMARK 465 ALA A 18 REMARK 465 SER A 19 REMARK 465 GLU A 20 REMARK 465 LEU A 21 REMARK 465 ASN A 22 REMARK 465 GLU A 23 REMARK 465 THR A 24 REMARK 465 GLN A 25 REMARK 465 GLU A 26 REMARK 465 PRO A 27 REMARK 465 PHE A 28 REMARK 465 LEU A 29 REMARK 465 ASN A 30 REMARK 465 PRO A 31 REMARK 465 THR A 32 REMARK 465 ASP A 33 REMARK 465 TYR A 34 REMARK 465 LEU A 384 REMARK 465 GLY A 385 REMARK 465 VAL A 386 REMARK 465 HIS A 387 REMARK 465 HIS A 388 REMARK 465 HIS A 389 REMARK 465 HIS A 390 REMARK 465 HIS A 391 REMARK 465 HIS A 392 REMARK 465 HIS A 393 REMARK 465 HIS A 394 REMARK 465 HIS A 395 REMARK 465 HIS A 396 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 232 -57.65 -126.16 REMARK 500 SER A1111 -31.96 -132.99 REMARK 500 PRO A1118 49.60 -89.72 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 OLA A 2002 REMARK 610 OLA A 2003 REMARK 610 OLA A 2004 REMARK 610 OLA A 2005 REMARK 610 1PE A 2006 REMARK 610 1PE A 2007 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7MA A 2001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLA A 2002 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLA A 2003 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLA A 2004 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue OLA A 2005 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 1PE A 2006 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 1PE A 2007 DBREF 5WS3 A 3 254 UNP O43614 OX2R_HUMAN 3 254 DBREF 5WS3 A 1001 1196 UNP Q9V2J8 Q9V2J8_PYRAB 218 413 DBREF 5WS3 A 294 388 UNP O43614 OX2R_HUMAN 294 388 SEQADV 5WS3 ASP A -6 UNP O43614 EXPRESSION TAG SEQADV 5WS3 TYR A -5 UNP O43614 EXPRESSION TAG SEQADV 5WS3 LYS A -4 UNP O43614 EXPRESSION TAG SEQADV 5WS3 ASP A -3 UNP O43614 EXPRESSION TAG SEQADV 5WS3 ASP A -2 UNP O43614 EXPRESSION TAG SEQADV 5WS3 ASP A -1 UNP O43614 EXPRESSION TAG SEQADV 5WS3 ASP A 0 UNP O43614 EXPRESSION TAG SEQADV 5WS3 ALA A 1 UNP O43614 EXPRESSION TAG SEQADV 5WS3 MET A 2 UNP O43614 EXPRESSION TAG SEQADV 5WS3 VAL A 308 UNP O43614 ILE 308 VARIANT SEQADV 5WS3 HIS A 389 UNP O43614 EXPRESSION TAG SEQADV 5WS3 HIS A 390 UNP O43614 EXPRESSION TAG SEQADV 5WS3 HIS A 391 UNP O43614 EXPRESSION TAG SEQADV 5WS3 HIS A 392 UNP O43614 EXPRESSION TAG SEQADV 5WS3 HIS A 393 UNP O43614 EXPRESSION TAG SEQADV 5WS3 HIS A 394 UNP O43614 EXPRESSION TAG SEQADV 5WS3 HIS A 395 UNP O43614 EXPRESSION TAG SEQADV 5WS3 HIS A 396 UNP O43614 EXPRESSION TAG SEQRES 1 A 560 ASP TYR LYS ASP ASP ASP ASP ALA MET GLY THR LYS LEU SEQRES 2 A 560 GLU ASP SER PRO PRO CYS ARG ASN TRP SER SER ALA SER SEQRES 3 A 560 GLU LEU ASN GLU THR GLN GLU PRO PHE LEU ASN PRO THR SEQRES 4 A 560 ASP TYR ASP ASP GLU GLU PHE LEU ARG TYR LEU TRP ARG SEQRES 5 A 560 GLU TYR LEU HIS PRO LYS GLU TYR GLU TRP VAL LEU ILE SEQRES 6 A 560 ALA GLY TYR ILE ILE VAL PHE VAL VAL ALA LEU ILE GLY SEQRES 7 A 560 ASN VAL LEU VAL CYS VAL ALA VAL TRP LYS ASN HIS HIS SEQRES 8 A 560 MET ARG THR VAL THR ASN TYR PHE ILE VAL ASN LEU SER SEQRES 9 A 560 LEU ALA ASP VAL LEU VAL THR ILE THR CYS LEU PRO ALA SEQRES 10 A 560 THR LEU VAL VAL ASP ILE THR GLU THR TRP PHE PHE GLY SEQRES 11 A 560 GLN SER LEU CYS LYS VAL ILE PRO TYR LEU GLN THR VAL SEQRES 12 A 560 SER VAL SER VAL SER VAL LEU THR LEU SER CYS ILE ALA SEQRES 13 A 560 LEU ASP ARG TRP TYR ALA ILE CYS HIS PRO LEU MET PHE SEQRES 14 A 560 LYS SER THR ALA LYS ARG ALA ARG ASN SER ILE VAL ILE SEQRES 15 A 560 ILE TRP ILE VAL SER CYS ILE ILE MET ILE PRO GLN ALA SEQRES 16 A 560 ILE VAL MET GLU CYS SER THR VAL PHE PRO GLY LEU ALA SEQRES 17 A 560 ASN LYS THR THR LEU PHE THR VAL CYS ASP GLU ARG TRP SEQRES 18 A 560 GLY GLY GLU ILE TYR PRO LYS MET TYR HIS ILE CYS PHE SEQRES 19 A 560 PHE LEU VAL THR TYR MET ALA PRO LEU CYS LEU MET VAL SEQRES 20 A 560 LEU ALA TYR LEU GLN ILE PHE ARG LYS LEU TRP CYS ARG SEQRES 21 A 560 GLN GLY ILE ASP CYS SER PHE TRP ASN GLU SER TYR LEU SEQRES 22 A 560 THR GLY SER ARG ASP GLU ARG LYS LYS SER LEU LEU SER SEQRES 23 A 560 LYS PHE GLY MET ASP GLU GLY VAL THR PHE MET PHE ILE SEQRES 24 A 560 GLY ARG PHE ASP ARG GLY GLN LYS GLY VAL ASP VAL LEU SEQRES 25 A 560 LEU LYS ALA ILE GLU ILE LEU SER SER LYS LYS GLU PHE SEQRES 26 A 560 GLN GLU MET ARG PHE ILE ILE ILE GLY LYS GLY ASP PRO SEQRES 27 A 560 GLU LEU GLU GLY TRP ALA ARG SER LEU GLU GLU LYS HIS SEQRES 28 A 560 GLY ASN VAL LYS VAL ILE THR GLU MET LEU SER ARG GLU SEQRES 29 A 560 PHE VAL ARG GLU LEU TYR GLY SER VAL ASP PHE VAL ILE SEQRES 30 A 560 ILE PRO SER TYR PHE GLU PRO PHE GLY LEU VAL ALA LEU SEQRES 31 A 560 GLU ALA MET CYS LEU GLY ALA ILE PRO ILE ALA SER ALA SEQRES 32 A 560 VAL GLY GLY LEU ARG ASP ILE ILE THR ASN GLU THR GLY SEQRES 33 A 560 ILE LEU VAL LYS ALA GLY ASP PRO GLY GLU LEU ALA ASN SEQRES 34 A 560 ALA ILE LEU LYS ALA LEU GLU LEU SER ARG SER ASP LEU SEQRES 35 A 560 SER LYS PHE ARG GLU ASN CYS LYS LYS ARG ALA MET SER SEQRES 36 A 560 PHE SER LYS GLN ILE ARG ALA ARG ARG LYS THR ALA ARG SEQRES 37 A 560 MET LEU MET VAL VAL LEU LEU VAL PHE ALA ILE CYS TYR SEQRES 38 A 560 LEU PRO ILE SER ILE LEU ASN VAL LEU LYS ARG VAL PHE SEQRES 39 A 560 GLY MET PHE ALA HIS THR GLU ASP ARG GLU THR VAL TYR SEQRES 40 A 560 ALA TRP PHE THR PHE SER HIS TRP LEU VAL TYR ALA ASN SEQRES 41 A 560 SER ALA ALA ASN PRO ILE ILE TYR ASN PHE LEU SER GLY SEQRES 42 A 560 LYS PHE ARG GLU GLU PHE LYS ALA ALA PHE SER CYS CYS SEQRES 43 A 560 CYS LEU GLY VAL HIS HIS HIS HIS HIS HIS HIS HIS HIS SEQRES 44 A 560 HIS HET 7MA A2001 32 HET OLA A2002 15 HET OLA A2003 16 HET OLA A2004 15 HET OLA A2005 17 HET 1PE A2006 13 HET 1PE A2007 13 HETNAM 7MA N-ETHYL-2-[(6-METHOXYPYRIDIN-3-YL)-(2-METHYLPHENYL) HETNAM 2 7MA SULFONYL-AMINO]-N-(PYRIDIN-3-YLMETHYL)ETHANAMIDE HETNAM OLA OLEIC ACID HETNAM 1PE PENTAETHYLENE GLYCOL HETSYN 1PE PEG400 FORMUL 2 7MA C23 H26 N4 O4 S FORMUL 3 OLA 4(C18 H34 O2) FORMUL 7 1PE 2(C10 H22 O6) FORMUL 9 HOH *12(H2 O) HELIX 1 AA1 ASP A 35 LEU A 48 1 14 HELIX 2 AA2 TYR A 53 ASN A 82 1 30 HELIX 3 AA3 HIS A 83 ARG A 86 5 4 HELIX 4 AA4 THR A 87 CYS A 107 1 21 HELIX 5 AA5 CYS A 107 GLU A 118 1 12 HELIX 6 AA6 PHE A 122 CYS A 157 1 36 HELIX 7 AA7 THR A 165 MET A 184 1 20 HELIX 8 AA8 MET A 184 VAL A 190 1 7 HELIX 9 AA9 GLU A 217 TYR A 232 1 16 HELIX 10 AB1 TYR A 232 CYS A 252 1 21 HELIX 11 AB2 ASN A 1008 LEU A 1012 5 5 HELIX 12 AB3 SER A 1015 GLY A 1028 1 14 HELIX 13 AB4 GLY A 1047 SER A 1059 1 13 HELIX 14 AB5 SER A 1060 GLN A 1065 5 6 HELIX 15 AB6 ASP A 1076 HIS A 1090 1 15 HELIX 16 AB7 SER A 1101 GLY A 1110 1 10 HELIX 17 AB8 GLY A 1125 LEU A 1134 1 10 HELIX 18 AB9 GLY A 1144 ILE A 1150 1 7 HELIX 19 AC1 ASP A 1162 ARG A 1178 1 17 HELIX 20 AC2 LEU A 1181 VAL A 329 1 52 HELIX 21 AC3 ASP A 338 SER A 368 1 31 HELIX 22 AC4 SER A 368 CYS A 383 1 16 SHEET 1 AA1 2 MET A 191 VAL A 196 0 SHEET 2 AA1 2 PHE A 207 GLU A 212 -1 O PHE A 207 N VAL A 196 SHEET 1 AA2 6 VAL A1093 ILE A1096 0 SHEET 2 AA2 6 MET A1067 ILE A1072 1 N ILE A1071 O ILE A1096 SHEET 3 AA2 6 VAL A1033 ILE A1038 1 N PHE A1035 O ARG A1068 SHEET 4 AA2 6 PHE A1114 ILE A1117 1 O ILE A1116 N MET A1036 SHEET 5 AA2 6 ILE A1137 SER A1141 1 O ILE A1139 N ILE A1117 SHEET 6 AA2 6 ILE A1156 VAL A1158 1 O VAL A1158 N ALA A1140 SSBOND 1 CYS A 127 CYS A 210 1555 1555 2.04 SITE 1 AC1 11 THR A 111 PRO A 131 GLN A 134 GLN A 187 SITE 2 AC1 11 GLU A 212 PHE A 227 ILE A 320 SER A 321 SITE 3 AC1 11 ASN A 324 HIS A 350 TYR A 354 SITE 1 AC2 1 OLA A2004 SITE 1 AC3 6 GLU A 54 TRP A 55 ILE A 62 LEU A 150 SITE 2 AC3 6 TYR A 154 LEU A 238 SITE 1 AC4 1 OLA A2002 SITE 1 AC5 6 TYR A 53 VAL A 56 LEU A 57 VAL A 179 SITE 2 AC5 6 ALA A 344 TRP A 351 SITE 1 AC6 8 LEU A 43 TYR A 47 THR A 204 THR A 205 SITE 2 AC6 8 SER A1022 LYS A1026 PHE A1104 GLU A1107 SITE 1 AC7 4 CYS A 210 LYS A 327 PHE A 333 PHE A 346 CRYST1 97.510 75.980 96.100 90.00 112.30 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010255 0.000000 0.004206 0.00000 SCALE2 0.000000 0.013161 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011247 0.00000